For colorectal cancer cells, AKR1B1 affects cellular proliferation and cell cycle progression, cell motility and expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NFKB) resulting in a poor prognosis for colorectal cancer patients [25]. This evidence concerns the gene NFKB1 and colorectal cancer.